98 related articles for article (PubMed ID: 28275633)
1. A risk assessment of a common drug using xenograft model.
Kodama M; Kurokawa J
Ann Transl Med; 2017 Feb; 5(4):88. PubMed ID: 28275633
[No Abstract] [Full Text] [Related]
2. A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening.
Jung DW; Oh ES; Park SH; Chang YT; Kim CH; Choi SY; Williams DR
Mol Biosyst; 2012 Jul; 8(7):1930-9. PubMed ID: 22569777
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of human uterine fibroid xenograft using sequential in vivo bioluminescence imaging.
Pan Y; Xiao T; Zhou Y; Chai Z; Xu Z; Dai M; Chen X; Suo G; Tao D
Am J Transl Res; 2019; 11(4):2359-2369. PubMed ID: 31105842
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.
Wang L; Chen H; Fei F; He X; Sun S; Lv K; Yu B; Long J; Wang X
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31107449
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a murine xenograft model for contrast agent development in breast lesion malignancy assessment.
Yen TH; Lee GD; Chai JW; Liao JW; Lau JY; Hu LC; Liao KC
J Biomed Sci; 2016 May; 23(1):46. PubMed ID: 27188327
[TBL] [Abstract][Full Text] [Related]
6. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
Jung J; Seol HS; Chang S
Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
[TBL] [Abstract][Full Text] [Related]
7. High ALDHdim-expressing CD34+CD38- cells in leukapheresed peripheral blood is a reliable guide for a successful leukemic xenograft model of acute myeloid leukemia.
Lee JY; Park S; Han AR; Lim J; Min WS; Kim HJ
Oncol Rep; 2014 Oct; 32(4):1638-46. PubMed ID: 25069538
[TBL] [Abstract][Full Text] [Related]
8. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
Kelland LR
Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
[TBL] [Abstract][Full Text] [Related]
9. Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model.
Tsukamoto Y; Kato Y; Ura M; Horii I; Ishikawa T; Ishitsuka H; Sugiyama Y
Biopharm Drug Dispos; 2001 Jan; 22(1):1-14. PubMed ID: 11745902
[TBL] [Abstract][Full Text] [Related]
10. PCR-based zebrafish model for personalised medicine in head and neck cancer.
Al-Samadi A; Tuomainen K; Kivimäki A; Salem A; Al-Kubati S; Hyytiäinen A; Parikka M; Mesimäki K; Wilkman T; Mäkitie A; Grenman R; Salo T
J Transl Med; 2019 Jul; 17(1):235. PubMed ID: 31331338
[TBL] [Abstract][Full Text] [Related]
11. Establishment of and comparison between orthotopic xenograft and subcutaneous xenograft models of gallbladder carcinoma.
Du Q; Jiang L; Wang XQ; Pan W; She FF; Chen YL
Asian Pac J Cancer Prev; 2014; 15(8):3747-52. PubMed ID: 24870787
[TBL] [Abstract][Full Text] [Related]
12. Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.
Koohestani F; Qiang W; MacNeill AL; Druschitz SA; Serna VA; Adur M; Kurita T; Nowak RA
Hum Reprod; 2016 Jul; 31(7):1540-51. PubMed ID: 27130615
[TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance in xenograft nude-mice by magnetic Fe(3)O(4) nanoparticles combined with daunorubicin and 5-bromotetrandrine.
Wu YN; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):60-4. PubMed ID: 19236748
[TBL] [Abstract][Full Text] [Related]
14. Cytokine Expression and Macrophage Localization in Xenograft and Allograft Tumor Models Stimulated with Lipopolysaccharide.
Masuda J; Shigehiro T; Matsumoto T; Satoh A; Mizutani A; Umemura C; Saito S; Kijihira M; Takayama E; Seno A; Murakami H; Seno M
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690614
[TBL] [Abstract][Full Text] [Related]
15. [Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer].
Qin B; Jiao X; Yuan L; Liu K; Zang Y
Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):715-719. PubMed ID: 29061220
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy.
Tong XM; Feng L; Suthe SR; Weng TH; Hu CY; Liu YZ; Wu ZG; Wang MH; Yao HP
J Immunother Cancer; 2019 Sep; 7(1):250. PubMed ID: 31519211
[TBL] [Abstract][Full Text] [Related]
17. Establishing a patient-derived xenograft model of human myxoid and round-cell liposarcoma.
Qi Y; Hu Y; Yang H; Zhuang R; Hou Y; Tong H; Feng Y; Huang Y; Jiang Q; Ji Q; Gu Q; Zhang Z; Tang X; Lu W; Zhou Y
Oncotarget; 2017 Aug; 8(33):54320-54330. PubMed ID: 28903344
[TBL] [Abstract][Full Text] [Related]
18. Reversal of doxorubicin resistance by guggulsterone of Commiphora mukul in vivo.
Xu HB; Shen ZL; Fu J; Xu LZ
Phytomedicine; 2014 Sep; 21(11):1221-9. PubMed ID: 25172783
[TBL] [Abstract][Full Text] [Related]
19. Scopoletin, an active principle of tree tobacco (Nicotiana glauca) inhibits human tumor vascularization in xenograft models and modulates ERK1, VEGF-A, and FGF-2 in computer model.
Tabana YM; Hassan LE; Ahamed MB; Dahham SS; Iqbal MA; Saeed MA; Khan MS; Sandai D; Majid AS; Oon CE; Majid AM
Microvasc Res; 2016 Sep; 107():17-33. PubMed ID: 27133199
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.
Schorlemmer HU; Kurrle R
Int J Tissue React; 1997; 19(3-4):149-56. PubMed ID: 9506316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
